Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Applied Optoelectronics led a broader retreat in photonics stocks on July 2, 2026, with Coherent and Lumentum sliding...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
AMD posted a blowout Q1 FY2026 with record revenue and booming data-center sales. The company guides stronger-than-ex...
Bitcoin tumbled toward $20,000 as a wave of selling and shifting flows rattled investors. A six-factor framework expl...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
Pi Network surged this week as bulls defend key support and push toward a 28-cent target, shaping a volatile yet cons...
Discover how to spot cash-flow opportunities in Zillow’s ranked market ripe. This guide breaks down how to evaluate d...
Ethereum breached a critical support level, signaling renewed downside risk. This report breaks down the factors, key...
Silver has tumbled since January, trading around $60 as markets weigh a possible comeback driven by industrial demand...
Qualcomm stock slid again in early March as Bank of America launched an Underperform rating, even after the company p...
Bitcoin rebounds into the $70k-$80k zone, but pandemic-style health headlines loom over the market. Traders weigh whe...